SMARCB1 and synovial sarcoma: However, a retargeting becomes evident in our data and has also been shown in data published on synovial sarcoma, a cancer entity in which BAF complexes contain an SS18-SSX fusion protein but also lose SMARCB1 in their complexes [80].